Drug development platform creator Xbiome has raised nearly $100m in series B funding while bioindustrial startup services provider 21st.Bio secured a similar amount from Novo.

Cambridge spinout Gyroscope, which counts Fosun as an investor, is set to be picked up for a healthy premium on the projected valuation at which it failed to float in May.

Corporate-backed unicorns Via and Cohesity have both confidentially filed to go public while autonomous driving technology developer Haomo.AI raised nearly $157m.

Mobile wallet developer Momo grabbed $200m in a Mizuho Bank-led round valuing it above $2bn while silicon wafer producer Mieke pulled in $188m.

China-based chipmakers Chipone Technology and Vastai Technologies raised a total of over $1.2bn while Reddit has confidentially filed to go public.

SoftBank invested in rounds for Olist, Open Co and Juspay while Innovaccer raised $150m.

Airtable, HealthCare.com and T11 pull in nine-figure rounds.

Cerebral, Robotic Research, ABclonal Technology, Ola and RainMed Medical all pulled in nine-figure rounds, the first two featuring SoftBank Vision Fund 2.

Incode and Odyssey Therapeutics each secured over $200m while Alvotech Holdings, BenevolentAI and Tomorrow.io have agreed reverse mergers at unicorn valuations.

Salesforce Ventures helped supply $62m for business intelligence software developer Klue while GS Retail invested $55m in mobility services provider Kakao Mobility.